Composition
- Active ingredients
- NIMODIPINE 30MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NIMODIPINE 30MG · CapsuleANDA076740-001 · Prescription
- NIMODIPINE 60MG/10ML · SolutionANDA213409-002 · Tentative approval
- NIMODIPINE 6MG/ML · SolutionANDA213409-001 · Prescription
- NIMODIPINE 30MG · CapsuleANDA077811-001 · Prescription
- NIMODIPINE 30MG · CapsuleANDA090103-001 · Prescription
- NIMODIPINE 30MG · CapsuleThis page
- NIMODIPINE 30MG · CapsuleANDA077067-001 · Discontinued
- NIMODIPINE 3MG/ML · SolutionANDA216937-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA201832.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Nimodipine
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Sofgen Pharms
- Status
- Discontinued
- FDA approval
- 24 Jul 2015
- Application
- ANDA201832-001